Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DU MARECHAL FOCH : revenue, balance sheet and financial ratios

SELARL PHARMACIE DU MARECHAL FOCH is a French company founded 10 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ANDRESY (78570), this company of category PME shows in 2024 a net income positive of 434 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DU MARECHAL FOCH (SIREN 812107498)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 433 740 € 328 242 € 366 023 € 231 263 € 205 297 € 154 744 € 127 995 € 277 045 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELARL PHARMACIE DU MARECHAL FOCH generates positive net income of 434 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 277 k€ -> 434 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

433 740 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 65%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 43%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

65.24%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

43.468%

Solvency indicators evolution
SELARL PHARMACIE DU MARECHAL FOCH

Sector positioning

Debt ratio
65.24 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average -5 pts over 3 years

In 2024, the debt ratio of SELARL PHARMACIE DU MAREC... (65.24) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
43.47% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average +7 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE DU MAREC... (43.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Positioning of SELARL PHARMACIE DU MARECHAL FOCH in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE DU MARECHAL FOCH is estimated at 6 055 331 € (range 4 216 836€ - 9 059 121€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
4216k€ 6055k€ 9059k€
6 055 331 € Range: 4 216 836€ - 9 059 121€
NAF 5 année 2024

Valuation method used

Net Income Multiple
433 740 € × 14.0x = 6 055 331 €
Range: 4 216 837€ - 9 059 122€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DU MARECHAL FOCH with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DU MARECHAL FOCH

What is the revenue of SELARL PHARMACIE DU MARECHAL FOCH ?

The revenue of SELARL PHARMACIE DU MARECHAL FOCH is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DU MARECHAL FOCH profitable?

Yes, SELARL PHARMACIE DU MARECHAL FOCH generated a net profit of 434 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE DU MARECHAL FOCH ?

The headquarters of SELARL PHARMACIE DU MARECHAL FOCH is located in ANDRESY (78570), in the department Yvelines.

Where to find the tax return of SELARL PHARMACIE DU MARECHAL FOCH ?

The tax return of SELARL PHARMACIE DU MARECHAL FOCH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DU MARECHAL FOCH operate?

SELARL PHARMACIE DU MARECHAL FOCH operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.